| The costs and benefits of automatic estimated glomerular filtration rate reporting. | |
| | |
MedLine Citation:
|
PMID: 19176794 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND AND OBJECTIVES: The prevalence of chronic kidney disease (CKD) has increased over the past two decades. The sensitivity of serum creatinine (sCr) to identify CKD is low. As a result, many healthcare centers report estimated GFR (eGFR) with routine blood work. The aim of this study was to determine the cost-effectiveness of automatic eGFR reporting compared with reporting sCr alone. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A Markov model was designed to evaluate the cost-effectiveness of reporting eGFR compared with reporting sCr alone in a hypothetical cohort of 60-yr-old individuals undergoing annual blood chemistry testing over 18 yr. Paths and path probabilities were identical between the two arms, except for the sensitivity and specificity of eGFR and sCr to detect CKD. RESULTS: eGFR reporting was dominant with a cost/effectiveness ratio of $16,751/quality-adjusted life year (QALY) versus $16,779/QALY for sCr reporting. Monte Carlo microsimulations in a hypothetical cohort of 10,000 patients demonstrated that over 18 yr, an average of 13 fewer deaths, 29 fewer ESRD events, and 11,348 more false positive CKD (FP-CKD) cases occurred with eGFR reporting. A sensitivity analysis revealed that decreasing the FP-CKD quality of life by > 2% rendered sCr reporting more cost-effective than eGFR reporting. If FP-CKD reduced quality of life by 5%, the incremental cost-effectiveness ratio for sCr reporting versus eGFR reporting would be $4367/QALY. CONCLUSION: A decision analysis suggests that reporting eGFR may be beneficial, but this limited benefit was reversed with virtually any reduction in quality of life caused by incorrect diagnosis of CKD. |
| | |
Authors:
|
Julia R den Hartog; Peter P Reese; Borut Cizman; Harold I Feldman |
Related Documents
:
|
11197584 - Trovafloxacin-associated leukopenia. 12564354 - Is acupuncture safe? a systematic review of case reports. 10585814 - Amphotericin b lipid complex (ablc)-associated hypertension: case report and review. 11953284 - Ocular involvement in takayasu's arteritis: response to cyclophosphamide therapy. 18286434 - Management of cutaneous juvenile hemangiomas. 22783694 - "hybrid" ameloblastoma: a report of two cases. |
Publication Detail:
|
Type: Comparative Study; Evaluation Studies; Journal Article Date: 2009-01-28 |
Journal Detail:
|
Title: Clinical journal of the American Society of Nephrology : CJASN Volume: 4 ISSN: 1555-905X ISO Abbreviation: Clin J Am Soc Nephrol Publication Date: 2009 Feb |
Date Detail:
|
Created Date: 2009-02-16 Completed Date: 2009-06-11 Revised Date: 2013-06-02 |
Medline Journal Info:
|
Nlm Unique ID: 101271570 Medline TA: Clin J Am Soc Nephrol Country: United States |
Other Details:
|
Languages: eng Pagination: 419-27 Citation Subset: IM |
Affiliation:
|
Internal Medicine, University of Virginia Health System, Charlottesville, Virginia, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Chronic Disease Computer Simulation Cost-Benefit Analysis Creatinine / blood* Decision Support Techniques Disease Progression False Positive Reactions Glomerular Filtration Rate* Humans Kidney Diseases / complications, diagnosis*, economics, mortality Kidney Failure, Chronic / economics, etiology*, mortality Kidney Function Tests / economics* Mandatory Programs / economics* Mandatory Reporting* Markov Chains Middle Aged Models, Economic Monte Carlo Method Predictive Value of Tests Program Evaluation Quality-Adjusted Life Years Sensitivity and Specificity |
| Chemical | |
Reg. No./Substance:
|
60-27-5/Creatinine |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Incidence, predictors, and associated outcomes of prostatism after kidney transplantation.
Next Document: Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.